<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="224837">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00155376</url>
  </required_header>
  <id_info>
    <org_study_id>940104</org_study_id>
    <nct_id>NCT00155376</nct_id>
  </id_info>
  <brief_title>Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <brief_summary>
    <textblock>
      Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile
      secretion and dilatation of bile duct. We conduct this randomized double blinded study to
      evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Morphine can induce constriction of sphincter of oddi and glucagon can facilitate bile
      secretion and dilatation of bile duct. We conduct this randomized double blinded study to
      evaluate the effect of enhancement in MRCP using intravenous morphine and glucagon.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2005</start_date>
  <completion_date>September 2005</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double-Blind</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MRCP visibility</measure>
  </primary_outcome>
  <enrollment>100</enrollment>
  <condition>Liver Disease</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>morphine and glucagon</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  normal volunteer

          -  living liver donor

        Exclusion Criteria:

          -  COPD

          -  chronic liver disease

          -  hypersensitive to glucagon

          -  DM

          -  insulinoma

          -  glucagonoma

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hon-Man Liu, MD</last_name>
    <role>Study Chair</role>
    <affiliation>National Taiwan University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yuan-Heng Mo, MD</last_name>
    <email>jamesmyh@ha.mc.ntu.edu.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>National Taiwan University Hospital</name>
      <address>
        <city>Taipei</city>
        <state>province of Taiwan</state>
        <zip>100</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuan-Heng Mo, MD</last_name>
      <email>jamesmyh@ha.mc.ntu.edu.tw</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>April 2005</verification_date>
  <lastchanged_date>November 25, 2005</lastchanged_date>
  <firstreceived_date>September 8, 2005</firstreceived_date>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Liver Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Glucagon</mesh_term>
    <mesh_term>Glucagon-Like Peptide 1</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
